Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen
Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen have?
Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen published?
Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen has 2026 year in the ScholarIQ index.
What is the open-access status of Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?
Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen has gold oa status in the ScholarIQ index.
What is the DOI of Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?
The DOI for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is on the source record.
What is the PMID of Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?
The PMID for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is on the source record.
What is the OpenAlex record for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?
The OpenAlex for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is on the source record.